Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Minneapolis, MN
SEC filing record 1 source field available
Fiscal year end
31 December
DiaMedica Therapeutics Inc. has filed 423 SEC EDGAR filings since 16 May 2007

SEC filing history

Showing 51-75 of 422 matching filings.

Per page
25
Current page
3
SCHEDULE 13G/A File 005-90788

SCHEDULE 13G/A filing

Filing date
30 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90788

SCHEDULE 13G/A filing

Filing date
30 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
25 Jul 2025
Reporting date
23 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
25 Jul 2025
Reporting date
23 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Jul 2025
Reporting date
23 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-552749

D filing

Filing date
25 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2025
Reporting date
01 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2025
Reporting date
01 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2025
Reporting date
01 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2025
Reporting date
01 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2025
Reporting date
01 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2025
Reporting date
01 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2025
Reporting date
01 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2025
Reporting date
01 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2025
Reporting date
07 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36291

ARS

Filing date
28 Mar 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36291

FORM DEFA14A

Filing date
28 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36291

FORM DEF 14A

Filing date
28 Mar 2025
Reporting date
15 May 2025
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .